Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
Differential Effects Between a Calcium Channel Blocker and a Diuretic When Used in Combination With Angiotensin II Receptor Blocker on Central Aortic Pressure in Hypertensive Patients
Hypertension, 08/13/09
Matsui Y et al. – The data showed that the combination of olmesartan and azelnidipine had a more beneficial effect on central systolic BP and arterial stiffness than the combination of olmesartan (20.0 mg) and hydrochlorothiazide, despite the lack of a significant difference in brachial systolic BP reduction between the 2 treatments.
Yoshio Matsui, 08/16/09
| The J-CORE study demonstrated that both the change in the pattern of arterial wave reflections and the decrease in arterial stiffness might contribute to a greater reduction in central SBP with the ARB/CCB treatment. Recently, the ACCOMPLISH study demonstrated that the combination of an ACE-I and a CCB was more effective than the combination of an ACE-I and a thiazide diuretic for decreasing cardiovascular events in high-risk hypertensive patients. Benefits were seen despite trivial differences in brachial SBP. Such a discrepancy between the difference of brachial SBP and clinical outcome was seen in the CAFÉ study and this was explained by the difference of central SBP. Because the central SBP and aortic PWV are independent predictors of cardiovascular morbidity in hypertensive patients, the benefits of the ACE-I/CCB combination in the ACCOMPLISH study may be attributable to a greater reduction in central SBP and arterial stiffness beyond the reduction in brachial SBP compared with that by the ACE-I/diuretic combination. |
Related Articles
Effective strategies for management of hypertension after vascular endothelial growth factor signaling inhibition therapy: Results from a phase II randomized, factorial, double-blind study of cediranib in patients with advanced solid tumors
Journal of Clinical Oncology, 11/13/09
Relevance Score: 94%
Practical strategies for management of hypertension in the elderly
Internet Source, 10/13/09
Relevance Score: 92%
Hypertension in Women: More Evidence for the Role of Lifestyle
Nursing for Women's Health, 10/12/09
Relevance Score: 92%
Hypertension treatment and management concerns in the elderly
Aging Health, 10/07/09
Relevance Score: 92%
Intradialytic Hypertension: A Less-Recognized Cardiovascular Complication of Hemodialysis
American Journal of Kidney Diseases, 10/28/09
Relevance Score: 91%
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Role of rho-kinase in the regulation of vascular tone in hypertensive renal transplant recipients
Atherosclerosis, 12/04/09
O-GlcNAcylation Contributes to Augmented Vascular Reactivity Induced by Endothelin
Hypertension, 12/03/09
Blood pressure in children and target-organ damage later in life
Pediatric Nephrology, 12/03/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Medium-size-vessel vasculitis
Pediatric Nephrology, 12/04/09
Sirolimus and Cyclosporine A Alter Barrier Function In Renal Proximal Tubular Cells through Stimulation of ERK 1/2 Signaling and Claudin-1 Expression
American Journal of Physiology: Renal Physiology, 12/04/09
Abnormalities of thyroid function in Japanese patients with metastatic renal cell carcinoma treated with sorafenib: A prospective evaluation
Urologic Oncology: Seminars and Original Investigations, 12/03/09
Article Search
Sponsor


See Latest Articles


